Reviewed by Laurence P. Banville, Esq.Frequently asked questions
What is the famotidine cancer lawsuit about?
Famotidine (sold as Pepcid and generics) was found by some testing to contain N-Nitrosodimethylamine (NDMA), a chemical classified as a probable human carcinogen. Patients who developed cancers such as stomach, esophageal, colorectal, or bladder cancer after prolonged use may have grounds to sue the manufacturers for failing to warn consumers of the contamination risk.
Who can file a famotidine cancer lawsuit in New York?
New York residents who took famotidine regularly and were subsequently diagnosed with a cancer linked to NDMA exposure may be eligible to file a claim. Eligible parties include patients, and in cases of death, surviving family members may bring a wrongful death action. An attorney can review your medical history, prescription records, and diagnosis to assess whether you have a viable claim.
What is the deadline to file a famotidine lawsuit in New York?
Under CPLR §214, New York’s general personal injury statute of limitations is three years from the date of injury or discovery of harm. However, product liability claims can be complex—the clock may run from when you knew or should have known your cancer was linked to famotidine. You should consult a NY attorney immediately to protect your right to sue before the deadline passes.
What evidence should I gather for a famotidine cancer lawsuit?
Preserve all pharmacy records, prescription bottles, receipts, and any documentation showing how long and how often you took famotidine. Collect your medical records showing your cancer diagnosis, treatment history, and pathology reports. A paper trail connecting your use of the drug to your diagnosis strengthens your claim significantly and should be assembled as soon as possible.